EnBio Holdings Inc. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
2,109
1,979
2,732
5,348
8,388
8,563
Cost of Goods Sold (COGS) incl. D&A
1,528
1,451
1,886
4,150
6,497
6,585
Gross Income
581
528
846
1,198
1,891
1,978
SG&A Expense
349
460
547
937
1,104
1,341
EBIT
232
68
298
-
787
637
Unusual Expense
2
-
13
1
20
-
Non Operating Income/Expense
14
5
10
51
22
539
Interest Expense
10
7
23
88
132
149
Pretax Income
188
47
249
102
652
60
Income Tax
84
35
106
49
245
95
Consolidated Net Income
105
12
143
53
406
155
Net Income
105
12
143
24
404
151
Net Income After Extraordinaries
105
12
143
24
404
151
Net Income Available to Common
105
12
143
24
404
151
EPS (Basic)
36.75
2.93
30.09
4.47
70.62
23.35
Basic Shares Outstanding
3
4
5
5
6
6
EPS (Diluted)
31.77
2.74
28.65
4.32
67.81
23.35
Diluted Shares Outstanding
3
4
5
6
6
6
EBITDA
239
75
339
438
1,137
1,146
Non-Operating Interest Income
-
1
1
1
2
1
Minority Interest Expense
-
-
1
29
3
4
Equity in Affiliates (Pretax)
17
19
31
22
2
10
About EnBio Holdings
View Profile
